BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 19134310)

  • 1. [Sequential intravenous and oral itraconazole in treatment of invasive fungal infection in hematological diseases].
    ; Chen Y; Shen ZX
    Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):1026-9. PubMed ID: 19134310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficacy and safety of itraconazole injection/oral solution sequential therapy for treatment of invasive fungal infection in intensive care unit].
    ; Qui HB
    Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):1012-6. PubMed ID: 19134307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A retrospective study of efficacy and safety of itraconazole for treatment of invasive fungal infection in hematologic diseases].
    Ji Y; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2008 Dec; 47(12):1022-5. PubMed ID: 19134309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of intravenous itraconazole followed by oral itraconazole solution in the treatment of invasive pulmonary mycosis.
    Zhang YY; Zhou X;
    Chin Med J (Engl); 2011 Oct; 124(20):3415-9. PubMed ID: 22088546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in china.
    Wang A; Zhang Y; He L; Shen Z; Liao W; Han M; Li R; Liang D; Wu S; Hahn-Ast C; Glasmacher A; Liekwok WA
    Jpn J Infect Dis; 2006 Dec; 59(6):370-6. PubMed ID: 17186955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a Chinese cohort.
    Cheng S; Zhou JF; Zou P; Huang XJ; Jin J; Shen ZX
    Chin Med J (Engl); 2011 Nov; 124(22):3670-5. PubMed ID: 22340222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of intravenous administration of itraconazole on fungal infections in immunocompromised patients with hematological diseases].
    Wang JZ; Huang XJ; Liu KY; Liu DH; Chen H; Xu LP; Lu J; Zhang YC; Han W; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1481-3. PubMed ID: 16061027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [An analysis of efficacy and related factors of itraconazole in the treatment of invasive fungal infection in hematological diseases].
    Liu CY; Fu R; Wu YH; Ruan EB; Qu W; Wang GJ; Liang Y; Wang XM; Liu H; Song J; Guan J; Wang HQ; Xing LM; Li LJ; Wang J; Shao ZH
    Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):504-7. PubMed ID: 20979739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical efficacy and safety of itraconazole injection in treatment of invasive fungal infection in intensive care unit].
    Collaborative Research Group of Itraconazole in Intensive Care Unit
    Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):414-7. PubMed ID: 20646417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
    Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
    Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the success rate of empirical antifungal therapy with intravenous itraconazole and clinical parameters, including plasma levels of itraconazole, in immunocompromised patients receiving itraconazole oral solution as prophylaxis: a multicenter, prospective, open-label, observational study in Korea.
    Kim JS; Cheong JW; Kim YK; Park J; Mun YC; Kang HJ; Yi HG; Lee JH; Kim YS; Ryoo HM; Kim SH; Kim HY; Kim JY; Lee DG; Kim HG; Kim H; Joo YD; Min YH
    Ann Hematol; 2014 Jan; 93(1):33-42. PubMed ID: 23807252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The clinical study of invasive fungal infection in 76 cases of hematologic diseases].
    Wu FF; Sun H; Gan SL; Ma J; Liu YF; Xie XS; Sun L; Liu LX; Wan DM
    Zhonghua Nei Ke Za Zhi; 2013 Mar; 52(3):218-20. PubMed ID: 23856113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
    Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ; Maziarz RT; Chandrasekar PH; Lazarus HM; Goldman M; Blumer JL; Leitz GJ; Territo MC
    Ann Intern Med; 2003 May; 138(9):705-13. PubMed ID: 12729424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Itraconazole 800 mg for the prophylaxis of fungal infections in patients with acute leukemia and severe neutropenia].
    Andrade M A; Puga L B; Guerra C C; Molina E J; Capurro C M
    Rev Med Chil; 2011 Sep; 139(9):1128-34. PubMed ID: 22215390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
    Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
    J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Itraconazole for treatment of fungal infections in patients undergoing allogeneic hematopoietic stem cell transplantation].
    Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2007 Jan; 46(1):29-31. PubMed ID: 17331384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
    Huang X; Chen H; Han M; Zou P; Wu D; Lai Y; Huang H; Chen X; Liu T; Zhu H; Wang J; Hu J
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1509-16. PubMed ID: 22469884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The impact of itraconazole versus fluconazole on the prevention of postoperative invasive fungal infections after orthotopic liver transplantation].
    Cai CJ; Yi SH; Guo Y; Li MR; Yi HM; Yang Y; Lu MQ; Chen GH
    Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):911-3. PubMed ID: 18261273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinical efficacy and cardiac safety of itraconazole injection in treatment of acute pulmonary invasive fungal infection in chronic pulmonary diseases in the elderly].
    Jia W; Li YC; Zhu YQ; Li GH; Zhou YL; Zhang DR; Zhao XY; Gao SL
    Zhonghua Nei Ke Za Zhi; 2010 Mar; 49(3):230-3. PubMed ID: 20450657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.